Atom Investors LP Arvinas, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $2.11 Million - $2.94 Million	-34,938 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $2.16 Million - $3.39 Million	-37,063 Reduced 51.48%	34,938 $2.31 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $1.27 Million - $5.33 Million	62,743 Added 677.72%	72,001 $6.12 Million
Q3 2020 Nov 13, 2020	BUY	$22.99 - $36.34 $212,841 - $336,435	9,258 New	9,258 $219,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $983M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.